Current status of diagnosis and treatment of primary biliary cholangitis and related challenges in China
10.3969/j.issn.1001-5256.2016.10.001
- VernacularTitle:中国原发性胆汁性胆管炎的诊治现状和挑战
- Author:
Lifeng WANG
1
;
Ke ZHANG
;
Fan YANG
Author Information
1. Liver Disease Research Center for Biological Therapy, 302 Hospital of PLA, Beijing 100039, China)
- Publication Type:Research Article
- Keywords:
liver cirrhosis, biliary;
diagnosis;
therapy;
editorial
- From:
Journal of Clinical Hepatology
2016;32(10):1833-1837
- CountryChina
- Language:Chinese
-
Abstract:
Primary biliary cholangitis, once named primary biliary cirrhosis, is a chronic cholestatic liver disease characterized by immune-mediated damage of small and medium-sized bile ducts. Recently, with the improvement in the knowledge of this disease and the wide application of new immunological and pathological detection techniques, the gap between China and Western countries in the diagnosis and treatment of PBC has been gradually narrowed, and a series of innovative findings and results have also been achieved. This article reviews these achievements and points out future challenges and possible solutions.
